Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported today that its preliminary fourth quarter revenues rose approximately 21 percent year over year, thanks to an increase of about 110 percent in revenues from its ePlex analyzers during the quarter.

For the three months ended Dec. 31, 2018, the company said it expects total revenues of about $19.4 million, including ePlex revenues of approximately $12.1 million. Analysts, on average, are expecting total revenues of $18.8 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Springer Nature announces €9,500 fee to make papers open-access in Nature and its family of journals.

An early SARS-CoV-2 alteration may have enabled it to spread more easily, according to the New York Times.

Librarians have concluded that notebooks that belonged to Charles Darwin that were thought to have been lost were actually likely stolen, CNN reports.

In PNAS this week: ultrarare variants contribute to aging-related hearing loss, telomeres of cells infected with herpesvirus, and more.